Which has grown faster, ACAD or IDYA?

Over the past five years, IDYA grew revenue faster — ACAD at a 19.70% CAGR versus IDYA at 45.80%.

Is ACAD or IDYA more profitable?

ACAD runs the higher net margin — ACAD at 33.42% versus IDYA at -74.75%.

How have ACAD and IDYA total returns compared?

Over the past 5 years, ACAD delivered 3.52% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Acadia Pharmaceuticals Inc. (ACAD) vs IDEAYA Biosciences, Inc. (IDYA)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and IDEAYA Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACAD

Acadia Pharmaceuticals Inc.

$3.41B

$19.94HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

IDYA

IDEAYA Biosciences, Inc.

$3.51B

$36.93HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — ACAD vs IDYA

growth of $100 · dividends reinvested · last 7y

ACAD -19.7% (-3.1%/yr)IDYA +240.1% (+19.1%/yr)IDYA compounded faster over this window

ACAD IDYA

ACAD vs IDYA: by the numbers

•IDYA is the larger company ($3.51B vs $3.41B market cap).
•ACAD is profitable (33.42% net margin) while IDYA runs a net loss (-74.75%).
•IDYA grew revenue faster over the past five years (45.80% vs 19.70% CAGR).

Metrics side by side

Valuation

Metric	ACAD	IDYA
P/E ratio	8.98	N/A
Forward P/E	32.37	N/A
P/S ratio	3.00	15.00
P/B ratio	2.61	2.93
EV / EBITDA	31.54	N/A
FCF yield	5.11%	N/A

Profitability

Metric	ACAD	IDYA
Gross margin	91.13%	-43.89%
Operating margin	7.59%	-72.84%
Net margin	33.42%	-74.75%
ROE	29.12%	-14.60%
ROIC	6.25%	-17.68%

Growth (annualized)

Metric	ACAD	IDYA
Revenue CAGR (5Y)	19.70%	45.80%
Total return CAGR (5Y)	3.52%	7.32%

Frequently asked

Which has grown faster, ACAD or IDYA?: Over the past five years, IDYA grew revenue faster — ACAD at a 19.70% CAGR versus IDYA at 45.80%.
Is ACAD or IDYA more profitable?: ACAD runs the higher net margin — ACAD at 33.42% versus IDYA at -74.75%.
How have ACAD and IDYA total returns compared?: Over the past 5 years, ACAD delivered 3.52% and IDYA delivered 7.32% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACAD analysis Full IDYA analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio Acadia Pharmaceuticals ROE IDEAYA Biosciences ROE Acadia Pharmaceuticals operating margin IDEAYA Biosciences operating margin Acadia Pharmaceuticals revenue growth IDEAYA Biosciences revenue growth Acadia Pharmaceuticals free cash flow IDEAYA Biosciences free cash flow

Acadia Pharmaceuticals & IDEAYA Biosciences appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.